Objective:To explore the common mechanism of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes by network pharmacology.Methods:All chemical components and targets of the four drugs in Hu...Objective:To explore the common mechanism of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes by network pharmacology.Methods:All chemical components and targets of the four drugs in Huanglian Jiedu Decoction were retrieved through TCMSP,and the genes were standardized through Uniprot database.Acquire disease targets related to coronary heart disease and diabetes in OMIM and GeneCards databases.The network diagram of"drug-component-target-disease"is constructed by using the software of cytopscape 3.7.2,the PPI network diagram of protein interaction is constructed by using STRING database,and the network diagram of"drug-disease"core target is constructed by using the software of cytopscape 3.7.2.DAVID's online database platform was used to analyze GO biological process and KEGG pathway enrichment of common targets of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes.Results:103 active ingredients of Huanglian Jiedu Decoction were retrieved,including 140 acting targets,5342 coronary heart disease targets,114 diabetes targets,and 14 common intersection targets of drugs and diseases,involving AR,PPARG,TNF,IL6,CCL2,VEGFA,PON1,etc.The GO biological process analysis results in 98 biological processes,10 cell components and 10 molecular functions.Among them are positive regulation of gene expression,positive regulation of nitric oxide biosynthesis process,Extracellular space,cytokine activity,steroid hormone receptor activity and other biological processes;The enrichment analysis of KEGG pathway yielded 20 signal pathways(P≤0.05).It mainly involves Malaria,cancer in cancer,HIF-1 signaling pathway,TNF signaling pathway,NOD-like receptor signaling pathway,PI3K-Akt signaling pathway,etc.Conclusion:Huanglian Jiedu Decoction"treats different diseases at the same time"coronary heart disease and type 2 diabetes have the characteristics of multiple components,multiple targets and multiple pathways,which provide theoretical basis for Huanglian Jiedu Decoction to treat coronary heart disease and type 2 diabetes in clinic,but the key targets and pathways of Huanglian Jiedu Decoction to treat diseases still need further experimental verification.展开更多
In order to inquire into the therapeutic effects of Xiao Shi Xiong Huang San (硝石雄黄散the Nitrum and Realgar Powder), one of the Dunhuang Prescription, on angina pectoris due to coronary heart disease (APCHD), the a...In order to inquire into the therapeutic effects of Xiao Shi Xiong Huang San (硝石雄黄散the Nitrum and Realgar Powder), one of the Dunhuang Prescription, on angina pectoris due to coronary heart disease (APCHD), the authors have treated 61 cases of APCHD by externally applying paste of the powder on Zhiyang (GV 9), with another 30 cases of APCHD treated with the nitroglycerin paste on Zhiyang as the controls. The results showed that the total effective rate was 82% and markedly effective rate 31.2% in the treatment group (the Paste of Nitrum and Realgar Powder), and the total effective rate was 46.6% and markedly effective rate 23.2% in the control group (the nitroglycerin paste). The difference in therapeutic effects between the two groups was very significant (P<0.01), indicating that the therapeutic effect of the former was significantly superior to that of the latter.展开更多
目的以“心脑同治”理论为依据,采用网络药理学与分子对接方法探究匝迪-5对缺血性心脏病和缺血性脑卒中的作用机制。方法通过TCMSP数据库与分析平台筛选得到匝迪-5中活性成分以及潜在靶点,从OMIM数据库、Gene Card数据库、药物靶标数据...目的以“心脑同治”理论为依据,采用网络药理学与分子对接方法探究匝迪-5对缺血性心脏病和缺血性脑卒中的作用机制。方法通过TCMSP数据库与分析平台筛选得到匝迪-5中活性成分以及潜在靶点,从OMIM数据库、Gene Card数据库、药物靶标数据库中获取缺血性心脏病和缺血性脑卒中疾病相关靶点,取交集获取相交靶点,建立“药材—化学成分—靶点—疾病”网络。构建蛋白相互作用网络,利用DAVID平台对相交靶蛋白进行GO富集分析和KEGG通路富集分析。运用Auto dock 4.2软件进行分子对接。结果筛选出疾病与药物相交靶点104个,关键靶点有CASP3、VEGFA、TNF等10个,相交靶点主要富集在MAPK信号通路、糖尿病并发症晚期糖基化终产物及其受体信号通路、Rap1信号通路等多条信号通路中。结论匝迪-5通过多种活性成分、多靶点、多途径作用于炎症反应、细胞凋亡等途径,治疗缺血性心脏病及缺血性脑卒中,实现“心脑同治”,为后续研究提供参考。展开更多
基金National Major Specialized Science and Technology Project for New Drugs Development(No.2017ZX09301003)。
文摘Objective:To explore the common mechanism of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes by network pharmacology.Methods:All chemical components and targets of the four drugs in Huanglian Jiedu Decoction were retrieved through TCMSP,and the genes were standardized through Uniprot database.Acquire disease targets related to coronary heart disease and diabetes in OMIM and GeneCards databases.The network diagram of"drug-component-target-disease"is constructed by using the software of cytopscape 3.7.2,the PPI network diagram of protein interaction is constructed by using STRING database,and the network diagram of"drug-disease"core target is constructed by using the software of cytopscape 3.7.2.DAVID's online database platform was used to analyze GO biological process and KEGG pathway enrichment of common targets of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes.Results:103 active ingredients of Huanglian Jiedu Decoction were retrieved,including 140 acting targets,5342 coronary heart disease targets,114 diabetes targets,and 14 common intersection targets of drugs and diseases,involving AR,PPARG,TNF,IL6,CCL2,VEGFA,PON1,etc.The GO biological process analysis results in 98 biological processes,10 cell components and 10 molecular functions.Among them are positive regulation of gene expression,positive regulation of nitric oxide biosynthesis process,Extracellular space,cytokine activity,steroid hormone receptor activity and other biological processes;The enrichment analysis of KEGG pathway yielded 20 signal pathways(P≤0.05).It mainly involves Malaria,cancer in cancer,HIF-1 signaling pathway,TNF signaling pathway,NOD-like receptor signaling pathway,PI3K-Akt signaling pathway,etc.Conclusion:Huanglian Jiedu Decoction"treats different diseases at the same time"coronary heart disease and type 2 diabetes have the characteristics of multiple components,multiple targets and multiple pathways,which provide theoretical basis for Huanglian Jiedu Decoction to treat coronary heart disease and type 2 diabetes in clinic,but the key targets and pathways of Huanglian Jiedu Decoction to treat diseases still need further experimental verification.
文摘In order to inquire into the therapeutic effects of Xiao Shi Xiong Huang San (硝石雄黄散the Nitrum and Realgar Powder), one of the Dunhuang Prescription, on angina pectoris due to coronary heart disease (APCHD), the authors have treated 61 cases of APCHD by externally applying paste of the powder on Zhiyang (GV 9), with another 30 cases of APCHD treated with the nitroglycerin paste on Zhiyang as the controls. The results showed that the total effective rate was 82% and markedly effective rate 31.2% in the treatment group (the Paste of Nitrum and Realgar Powder), and the total effective rate was 46.6% and markedly effective rate 23.2% in the control group (the nitroglycerin paste). The difference in therapeutic effects between the two groups was very significant (P<0.01), indicating that the therapeutic effect of the former was significantly superior to that of the latter.
文摘目的以“心脑同治”理论为依据,采用网络药理学与分子对接方法探究匝迪-5对缺血性心脏病和缺血性脑卒中的作用机制。方法通过TCMSP数据库与分析平台筛选得到匝迪-5中活性成分以及潜在靶点,从OMIM数据库、Gene Card数据库、药物靶标数据库中获取缺血性心脏病和缺血性脑卒中疾病相关靶点,取交集获取相交靶点,建立“药材—化学成分—靶点—疾病”网络。构建蛋白相互作用网络,利用DAVID平台对相交靶蛋白进行GO富集分析和KEGG通路富集分析。运用Auto dock 4.2软件进行分子对接。结果筛选出疾病与药物相交靶点104个,关键靶点有CASP3、VEGFA、TNF等10个,相交靶点主要富集在MAPK信号通路、糖尿病并发症晚期糖基化终产物及其受体信号通路、Rap1信号通路等多条信号通路中。结论匝迪-5通过多种活性成分、多靶点、多途径作用于炎症反应、细胞凋亡等途径,治疗缺血性心脏病及缺血性脑卒中,实现“心脑同治”,为后续研究提供参考。
